DE2509885C3 - 1 -N-(2-Hydroxy-3-amim>propionyl)-XK-62-2, dessen Salze und seine Verwendung bei der Bekämpfung bakterieller Infektionen - Google Patents

1 -N-(2-Hydroxy-3-amim>propionyl)-XK-62-2, dessen Salze und seine Verwendung bei der Bekämpfung bakterieller Infektionen

Info

Publication number
DE2509885C3
DE2509885C3 DE2509885A DE2509885A DE2509885C3 DE 2509885 C3 DE2509885 C3 DE 2509885C3 DE 2509885 A DE2509885 A DE 2509885A DE 2509885 A DE2509885 A DE 2509885A DE 2509885 C3 DE2509885 C3 DE 2509885C3
Authority
DE
Germany
Prior art keywords
hydroxy
mixture
acid
solution
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2509885A
Other languages
German (de)
English (en)
Other versions
DE2509885B2 (de
DE2509885A1 (de
Inventor
Yasuki Kawasaki Kanagawa Mori
Shinji Machida Tokio Tomioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE2509885A1 publication Critical patent/DE2509885A1/de
Publication of DE2509885B2 publication Critical patent/DE2509885B2/de
Application granted granted Critical
Publication of DE2509885C3 publication Critical patent/DE2509885C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2509885A 1974-03-07 1975-03-06 1 -N-(2-Hydroxy-3-amim>propionyl)-XK-62-2, dessen Salze und seine Verwendung bei der Bekämpfung bakterieller Infektionen Expired DE2509885C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2575374A JPS573679B2 (US07794700-20100914-C00152.png) 1974-03-07 1974-03-07

Publications (3)

Publication Number Publication Date
DE2509885A1 DE2509885A1 (de) 1975-09-11
DE2509885B2 DE2509885B2 (de) 1977-12-08
DE2509885C3 true DE2509885C3 (de) 1978-08-17

Family

ID=12174581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2509885A Expired DE2509885C3 (de) 1974-03-07 1975-03-06 1 -N-(2-Hydroxy-3-amim>propionyl)-XK-62-2, dessen Salze und seine Verwendung bei der Bekämpfung bakterieller Infektionen

Country Status (14)

Country Link
JP (1) JPS573679B2 (US07794700-20100914-C00152.png)
AT (1) AT340588B (US07794700-20100914-C00152.png)
CA (1) CA1046057A (US07794700-20100914-C00152.png)
CH (1) CH613710A5 (US07794700-20100914-C00152.png)
DE (1) DE2509885C3 (US07794700-20100914-C00152.png)
DK (1) DK88475A (US07794700-20100914-C00152.png)
ES (1) ES435375A1 (US07794700-20100914-C00152.png)
FR (1) FR2263251B1 (US07794700-20100914-C00152.png)
GB (1) GB1500218A (US07794700-20100914-C00152.png)
NL (1) NL7502740A (US07794700-20100914-C00152.png)
NO (1) NO140428C (US07794700-20100914-C00152.png)
PH (1) PH13670A (US07794700-20100914-C00152.png)
SE (1) SE416208B (US07794700-20100914-C00152.png)
ZA (1) ZA751414B (US07794700-20100914-C00152.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136254A (en) 1976-06-17 1979-01-23 Schering Corporation Process of selectively blocking amino functions in aminoglycosides using transition metal salts and intermediates used thereby
EP0000057B1 (de) * 1977-06-10 1982-07-14 Bayer Ag Selektiv geschützte 4,6-Di-O-(aminoglycosyl)-1,3-diaminocyclitole

Also Published As

Publication number Publication date
ZA751414B (en) 1976-10-27
JPS573679B2 (US07794700-20100914-C00152.png) 1982-01-22
JPS50117748A (US07794700-20100914-C00152.png) 1975-09-16
SE416208B (sv) 1980-12-08
DK88475A (US07794700-20100914-C00152.png) 1975-09-08
CH613710A5 (en) 1979-10-15
CA1046057A (en) 1979-01-09
DE2509885B2 (de) 1977-12-08
NO140428C (no) 1979-08-29
FR2263251A1 (US07794700-20100914-C00152.png) 1975-10-03
ES435375A1 (es) 1977-05-01
AT340588B (de) 1977-12-27
NO750720L (US07794700-20100914-C00152.png) 1975-09-09
DE2509885A1 (de) 1975-09-11
GB1500218A (en) 1978-02-08
PH13670A (en) 1980-08-26
ATA173875A (de) 1977-04-15
NL7502740A (nl) 1975-09-09
NO140428B (no) 1979-05-21
FR2263251B1 (US07794700-20100914-C00152.png) 1977-07-22

Similar Documents

Publication Publication Date Title
DE2742949C2 (de) 4-N-Acylfortimicin B-Derivate und deren Verwendung
DE2758165A1 (de) 3-de-o-methylfortimicine und verfahren zu ihrer herstellung
DE2350169C3 (de) 19.10.72 Japan 103988-72 11.12.72 Japan 123482-72 23.01.73 Japan 9146-73 1-N- [(S)-2-Hydroxy-4-amino-butyryl] -neamin-Derivate, Verfahren zu ihrer Herstellung und solche Derivate enthaltende Arzneimittel
DE2502935A1 (de) Verfahren zur herstellung von 1-n- eckige klammer auf l-(-)-alpha-hydroxygamma-aminobutyryl eckige klammer zu -xk-62-2
DE2411504C3 (de) 6'-Substituierte 6'-Desoxylividomycine B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2332485A1 (de) Gentamicinderivate und verfahren zu deren herstellung
DE2502296C2 (de) 1-N-(S)-3-Amino-2-hydroxypropionyl- und 1-N-(S)-4-Amino-2-hydroxybutyryl-substituierte 4,6-Di-(aminoglycosyl)-1,3-diaminocyclitole und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2724597B2 (de) 3'-Desoxykanamycin C und 3',4'-Didesoxykanamycin C, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE2509885C3 (de) 1 -N-(2-Hydroxy-3-amim>propionyl)-XK-62-2, dessen Salze und seine Verwendung bei der Bekämpfung bakterieller Infektionen
DE2458921C3 (de) N-(2-Hydroxy-4-aminobutyryl)-Derivate des Antibiotikums XK-62-2, ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2818822C2 (US07794700-20100914-C00152.png)
DE2534982C3 (de) 1-N- [(L)-2-Hydroxy-5-aminovaleroylJ- und 1-N-[(L)-2-Hydroxy-6-aminocaproyl] -XK-62-2, deren pharmazeutisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung
DE2825289C3 (de) Kanamycinen und Ribostamycinen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
DE2423591C3 (de) 1-N-Isoserylkanamycine, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel
DE2361159B2 (de) 3'-Desoxy-neamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2820637A1 (de) Fortimicin-derivate und ihre salze, verfahren zu ihrer herstellung und ihre verwendung bei der bekaempfung bakterieller infektionen
DE2855350A1 (de) Fortimicin b-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2352361A1 (de) Antibiotische derivate
DE2723417C3 (de) 5,6-Epineamin und dessen Verwendung bei der Bekämpfung bakterieller Infektionen
DE2631462C3 (de) Derivate des Antibiotikums XK-62-2, deren Salze mit Säuren, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung bakterieller Infektionen
DE2720199B2 (de) 5,6-Didesoxy-neamin und Verfahren zu dessen Herstellung
DE2741431C3 (de) l-N-(L-4-Amino-2-hydroxybutyryl)-3'-desoxykanamycin-C, l-N-(L-4-Amino-2hydroxybutyryl)-3',4'-didesoxykanamycin-C und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Zusammensetzungen
DE2458920A1 (de) Verfahren zur herstellung von 1-n- eckige klammer auf l-(-)-alpha-hydroxy- gamma-aminobutyryl eckige klammer zu- xk-62-2
DE3004178A1 (de) 3',4'-didesoxykanamycin a und dessen 1-n-((s)- alpha -hydroxy- omega -aminoalkanoyl)-derivate sowie salze dieser verbindungen mit saeuren, verfahren zu ihrer herstellung und ihre verwendung als antibakterielle wirkstoffe
AT356266B (de) Verfahren zur herstellung von aminocyclitol- -antibiotika

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee